We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$13B
AUM Growth
+$3.62B
Cap. Flow
+$2.76B
Cap. Flow %
21.17%
Top 10 Hldgs %
22.9%
Holding
2,054
New
301
Increased
1,315
Reduced
342
Closed
62

Sector Composition

Rank Sector Weight
1 Technology 17.48%
2 Financials 9.37%
3 Healthcare 6.07%
4 Industrials 5.62%
5 Consumer Discretionary 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOBL icon
151
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
$17.9M 0.14%
355,758
+109,220
+44% +$5.4M
LMBS icon
152
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.32B
$17.8M 0.14%
361,143
+173,505
+92% +$8.49M
DVY icon
153
iShares Select Dividend ETF
DVY
$24B
$17.7M 0.14%
133,408
+12,387
+10% +$1.6M
TLT icon
154
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$17.6M 0.14%
200,340
+31,835
+19% +$2.78M
EFV icon
155
iShares MSCI EAFE Value ETF
EFV
$27.6B
$17.3M 0.13%
272,525
+103,925
+62% +$6.36M
IWD icon
156
iShares Russell 1000 Value ETF
IWD
$82B
$17.2M 0.13%
88,728
+15,004
+20% +$2.78M
MCK icon
157
McKesson
MCK
$98.5B
$17.1M 0.13%
23,270
+18,410
+379% +$13M
PFE icon
158
Pfizer
PFE
$140B
$17M 0.13%
703,411
+50,778
+8% +$1.18M
CGUS icon
159
Capital Group Core Equity ETF
CGUS
$11.1B
$16.9M 0.13%
456,595
+80,438
+21% +$2.74M
HON icon
160
Honeywell
HON
$77B
$16.8M 0.13%
76,381
+29,207
+62% +$5.91M
VOT icon
161
Vanguard Mid-Cap Growth ETF
VOT
$19B
$16.7M 0.13%
58,862
+12,515
+27% +$3.23M
XLE icon
162
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$16.7M 0.13%
394,782
-44,654
-10% -$1.86M
WEC icon
163
WEC Energy
WEC
$37.7B
$16.5M 0.13%
158,557
+44,213
+39% +$4.7M
IDEV icon
164
iShares Core MSCI International Developed Markets ETF
IDEV
$31B
$16.3M 0.12%
213,693
+35,284
+20% +$2.55M
DGX icon
165
Quest Diagnostics
DGX
$25.1B
$16.1M 0.12%
89,671
+64,095
+251% +$11.1M
IWR icon
166
iShares Russell Mid-Cap ETF
IWR
$56.8B
$16M 0.12%
174,305
+6,352
+4% +$549K
ZTS icon
167
Zoetis
ZTS
$31.6B
$15.9M 0.12%
102,174
+38,788
+61% +$6.15M
HYLS icon
168
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
$15.9M 0.12%
380,787
+76,663
+25% +$3.16M
CL icon
169
Colgate-Palmolive
CL
$72.6B
$15.6M 0.12%
171,225
+40,250
+31% +$3.67M
CME icon
170
CME Group
CME
$92.2B
$15.5M 0.12%
56,257
+12,089
+27% +$3.29M
NOW icon
171
ServiceNow
NOW
$102B
$15.3M 0.12%
74,580
+14,515
+24% +$2.74M
TXN icon
172
Texas Instruments
TXN
$255B
$15.3M 0.12%
73,651
+40,437
+122% +$7.18M
TGT icon
173
Target
TGT
$62.1B
$14.9M 0.11%
150,689
-50,841
-25% -$4.88M
SYK icon
174
Stryker
SYK
$127B
$14.8M 0.11%
37,349
+7,677
+26% +$2.87M
XLF icon
175
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$14.8M 0.11%
282,102
+64,302
+30% +$3.18M

Similar funds

&Partners's Q2 2025 Portfolio in Review

As of Q2 2025, &Partners held 2,054 positions worth $13B, up 38% from $9.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

&Partners deployed $2.76B of net new capital in Q2 2025, opening 301 new positions and adding to 1,315 existing holdings. Its largest new stake was GMO US Quality ETF: 259,884 shares worth $8.98M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Analog Devices, an estimated $16.1M trimmed.

  • &Partners's largest Q2 2025 buy was GMO US Quality ETF: 259,884 shares worth $8.98M.
  • &Partners added most to Microsoft in Q2 2025, an estimated $96.6M increase.
  • &Partners's biggest Q2 2025 reduction was Analog Devices, cutting an estimated $16.1M.
  • &Partners fully exited Vanguard US Multifactor ETF in Q2 2025, selling an estimated $1.6M.
  • &Partners's ten largest holdings make up 23% of its $13B portfolio in Q2 2025.
  • &Partners opened 301 new positions and closed 62 in Q2 2025.
  • &Partners's portfolio value rose 38% quarter-over-quarter to $13B.

Based on &Partners's 13F filing for Q2 2025, filed 14 Aug 2025.